(NYSE: ZBH) Zimmer Biomet Holdings's forecast annual revenue growth rate of 5.53% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.2%.
Zimmer Biomet Holdings's revenue in 2025 is $7,698,500,000.On average, 11 Wall Street analysts forecast ZBH's revenue for 2025 to be $1,619,742,127,839, with the lowest ZBH revenue forecast at $1,609,292,791,317, and the highest ZBH revenue forecast at $1,625,399,588,368. On average, 11 Wall Street analysts forecast ZBH's revenue for 2026 to be $1,713,206,857,900, with the lowest ZBH revenue forecast at $1,690,473,739,183, and the highest ZBH revenue forecast at $1,732,751,855,652.
In 2027, ZBH is forecast to generate $1,784,197,254,289 in revenue, with the lowest revenue forecast at $1,751,830,328,070 and the highest revenue forecast at $1,807,736,207,478.